DSD-C214

46,XX DSD — congenital adrenal hyperplasia (21-hydroxylase deficiency). · 46,XX · DSD-C214

DSD-C214 · 46,XX DSD — congenital adrenal hyperplasia (21-hydroxylase deficiency).

Genes CYP21A2 · Karyotype 46,XX · Phenotypes HPO:0000028, HPO:0000047, Hypospadias (HP:0000047), Cryptorchidism (HP:0000028)

Classical 21-OHD (46,XX CAH), virilizing form (Prader V), decompensated; with virilized external genitalia, bilateral adrenal masses, obesity; 46,XX karyotype, male social sex.

Images · 2

Case fields and evidence

Category

46,XX DSD — congenital adrenal hyperplasia (21-hydroxylase deficiency).

Age

49 years (social male).

Sex

Male social sex, male gender identity, male-type external genitalia; chromosomal 46,XX.

Karyotype

46,XX

Genetics

CYP21A2

Phenotypes

Hypospadias (HP:0000047); Cryptorchidism (HP:0000028)

Diagnosis

Classical 21-OHD (46,XX CAH), virilizing form (Prader V), decompensated; with virilized external genitalia, bilateral adrenal masses, obesity; 46,XX karyotype, male social sex.

Follow-up

Urological surgeries 2006, 2015 (urethral stricture/urethroplasty); dexamethasone since 2018; regimen adjusted 2019; long gap in follow-up (no records 2006–2015); long-term follow-up not reported.

General phenotype

Male phenotype (male body habitus, androgen-dependent hair, android alopecia), male gender identity; android obesity; male-type external genitalia, absent scrotal testes.

Imaging

Pelvic US (2006): thick-walled cystic structure behind bladder (uterus); CT/MRI: both adrenals enlarged, nodular, right 20 mm, left 13×15 mm masses; pelvic MRI: enlarged uterine cavity communicating with prostatic urethra; no testes in abdomen/pelvis.

Laboratory findings

2006: testosterone >55 nmol/L (high), ACTH 322 (high), LH 0.3, FSH 0.23 (low), PRL 1.465; 2019 on dexamethasone 2 mg/d: 17-OHP 31.5 (high), renin 70.6 (high), aldosterone 447.7 (high, hidden mineralocorticoid deficiency), testosterone <0.69, free T 0.21, DHEA-S 0.1, androstenedione 0.9, cortisol <27.6, ACTH 184; K 3.5–3.7, Na 140.

Management

Dexamethasone switched to prednisolone 10 mg/d (5 mg bid) plus mineralocorticoid Cortineff 50 μg/d; hypocaloric diet and exercise; after hormonal compensation, urological surgery planned (hysterectomy, oophorectomy, bladder plasty, scrotal testicular prostheses).

Pathology

Bilateral adrenal masses (CT/MRI nodular, enhancing) considered adrenal tumors (no biopsy/resection histology reported); pelvic cystic structure was uterus.

Clinical history

See source

Perinatal history

See source

Family history

See source

Growth and development

See source

External genital examination

See source

Puberty / Tanner

See source

Cite this resource

DSD Research Library | 46,XX DSD — congenital adrenal hyperplasia (21-hydroxylase deficiency). · 46,XX · DSD-C214 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-C214?version=v1.4.0